Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Finding biomarkers for predicting anti-tumor responses and immune-related adverse events (irAEs) with immune checkpoint therapy remains a challenge. Lozano et al. have developed a composite biomarker score that includes the frequency of effector-memory CD4 T cells and TCR clonality of CD4 T cells in peripheral blood as a potentially predictive biomarker of irAEs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ccell.2022.02.015 | DOI Listing |
Publication Analysis
Top Keywords
immune-related adverse
8
adverse events
8
cd4 t cells
8
composite t cell
4
t cell biomarker
4
biomarker pre-treatment
4
pre-treatment blood
4
blood samples
4
samples correlates
4
correlates detection
4